top of page

Scientific studies on mRNA

Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age

Cardiac

Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19

Cardiac

Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents

Cardiac

Myopericarditis following both BNT162b2 and NVX-CoV2373

Cardiac

Myopericarditis following COVID-19 vaccination in adolescent triplets

Cardiac

Myopericarditis following SARS-CoV-2 mRNA vaccine, the role of cardiac biomarkers and multimodality imaging

Cardiac

Myopericarditis Following the Third Dose of COVID-19 mRNA Vaccination, A Case Report

Cardiac

Myopericarditis in a Male Adolescent Following the Second Shot of COVID-19 Pfizer m-RNA Vaccine, Typical Example and Analysis of 110 Single Case Reports

Cardiac

Myopericarditis in a previously healthy 16yo male following COVID-19 vaccination, A case report

Cardiac

Myopericarditis in a Young Adult Secondary to COVID-19 Vaccination

Cardiac

Myopericarditis in young adults presenting to the emergency department after receiving a second COVID-19 mRNA vaccine

Cardiac

Myopericarditis with hemorrhagic pericardial effusion following BNT162b2 mRNA COVID-19 vaccine

Cardiac

Myopericarditis with Significant Left Ventricular Dysfunction Following COVID-19 Vaccination, A Case Report

Cardiac

Note the distinction between myocarditis, novel coronavirus myocarditis and COVID-19 vaccine-associated myocarditis

Cardiac

Novel case of takotsubo cardiomyopathy following COVID-19 vaccination

Cardiac

Occurrence of acute infarct-like myocarditis following COVID-19 vaccination, just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis

Cardiac

Outcome of Post-Covid Vaccination Myocarditis in an Adolescent Male

Cardiac

Pathological findings of clinically suspected myocarditis temporally associated with COVID-19 vaccination

Cardiac

Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination

Cardiac

Pericarditis after administration of the BNT162b2 mRNA vaccine against COVID-19

Cardiac
bottom of page